Skip to content

Move Together Boston Feasibility Pilot (Sit Less, Move More App for Black Breast Cancer Survivors & At-Risk Relatives)

Sitting Less, Moving More: Designing a Digital Health Intervention for Black and African American Women Breast Cancer Survivors and Their At-risk Relatives (Phase II)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05011279
Enrollment
10
Registered
2021-08-18
Start date
2021-09-10
Completion date
2022-01-21
Last updated
2023-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Breast Cancer Survivor, Fitness Trackers

Keywords

Digital Health Intervention, Breast Cancer Survivor, Breast Cancer, Garmin Activity Tracker, Move Together App, Fitness trackers

Brief summary

The purpose of this study is to develop and test a mobile app for Black/African American breast cancer survivors and their relatives, called Move Together, that promotes sitting less and moving more for better health.

Detailed description

The purpose of this study is to develop and test a mobile app for Black/African American breast cancer survivors and their relatives, called Move Together, that promotes sitting less and moving more for better health. This is a cross-sectional descriptive study using structured interviews and qualitative data analysis to develop an intervention, followed by a pilot test of the intervention with pre- /post- measures. * In study phase 1,involved qualitative interviews with 5 community leader key informants, 9 breast cancer survivors and 6 first degree relatives of a survivor. * This part of the research study is a Pilot Study, which means it is the first time that researchers are studying usability and acceptability of the Move Together app. * Participants in the pilot study will participate as members of family-based dyads (n=10 dyads). One member of each dyad will be a breast cancer survivor and one will be a blood relative * Study involves screening for eligibility, interviews, questionnaires, Use of Move Together app with Garmin activity tracker watch * Participation on the trial will be for 5 weeks * About 20 people (10 survivors with 10 relatives) will participate in this part of the study, and a total of 58 people in the whole study.

Interventions

OTHERMove Together app/Garmin Activity Tracker

* The Move Together app allows users to set daily goals for increasing physical activity and decreasing sedentary time, track progress on goals, message their buddy, and access external educational infographics and other resource links. * Garmin activity tracker in this study is for participants to track their steps and sedentary time.

Sponsors

University of Massachusetts, Boston
CollaboratorOTHER
University of Rochester
CollaboratorOTHER
National Cancer Institute (NCI)
CollaboratorNIH
Dana-Farber Cancer Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 1a) Key informants (for interviews) * Members of the community/advisory groups, community health centers, or faith-based network members (e.g., Pink and Black, Faces of Faith). * English speaking adults. * (1b) Breast cancer survivors and relatives (for interviews) * Self-identify as Black or African American * Age 18 and over * English speaking * Female breast cancer survivor status post curative antineoplastic treatment (except ongoing hormonal treatment) with no evidence of disease, OR a first degree blood relative (parent, child, or full sibling), of any gender, of a so defined breast cancer survivor * Self-report ever using a smart phone * (2) Breast cancer survivors and relatives (for user testing/interviews) * Self-identify as Black or African American * Age 18 and over * English speaking * Female breast cancer survivor status post curative antineoplastic treatment (except ongoing hormonal treatment) with no evidence of disease, OR a first degree blood relative (parent, child, or full sibling), of any gender, of a so defined breast cancer survivor * Self-report willing/able to download the app for testing on a smart phone * Self-report willing/able to meet via Zoom for interview * (3) Breast cancer survivors and relatives/buddies (for pilot testing) * Self-identify as Black or African American * Age 18 and over * English speaking * Breast cancer survivor status post curative antineoplastic treatment (except ongoing hormonal treatment) with no evidence of disease, OR a blood relative, of any gender, of a so defined breast cancer survivor * Self-report willing/able to participate with a blood relative in survivor relative dyad * Self-report willing/able to download the app for use on a smart phone * Self-report willing/able to meet via Zoom for instructions and interview

Exclusion criteria

* (1a) Key informants (for interviews) --None * (1b) Breast cancer survivors and relatives (for interviews) * Requires medically supervised physical activity (Physical Activity Readiness Question for Everyone, PAR-Q+, Question 7) * Pregnant women * (2) Breast cancer survivors and relatives (for user testing/interviews) * Requires medically supervised physical activity (Physical Activity Readiness Question for Everyone, PAR-Q+, Question 7) * Pregnant women * (3) Breast cancer survivors and relatives/buddies (for pilot testing) * Meets exclusion criterion of the Modified Physical Activity Readiness Questionnaire (PAR-Q) (modified) * Participated in interviews or user testing in prior phases of the study

Design outcomes

Primary

MeasureTime frameDescription
System Usability Scale (SUS) ScoreAssessed at 4 WeeksThe acceptability of the Move Together app will also be assessed with The System Usability Scale (SUS) score. The scale has 10 items. Scores range from 0-100; a SUS score above a 68 is considered above average (https://www.usability.gov/how-to-and-tools/methods/system-usability-scale.html.)

Secondary

MeasureTime frameDescription
Number of Participants Enrolled Per Month4 month enrollment periodnumber of participants consented to the study each month during enrollment period
Completion Rate4 Weeksnumber of participants who completed all aspects of the protocol
Number of Study Daysbaseline to 4 weeks (28 days)number of study days in which the participants uses the Move Together app and will describe engagement with the app in a 28 day period (i.e., study days)
Number of Participants Screened Per Month4 month recruitment periodthe number of participants screened per month during recruitment period (not cumulative)
Number of Participants Completed Study4 weeksTotal number of participants who completed the study
Number of Participants Retained at the End of 4 WeeksBaseline to 4 WeeksRetention will be the number who remain in the study at the end of 4 weeks
Number of Participants Recruitedduring 4 month recruitment periodNumber of initial respondents who consent and enroll.

Countries

United States

Participant flow

Participants by arm

ArmCount
Pilot Study
Participants in the pilot study will participate as members of family-based dyads (n=5 dyads). One member of each dyad will be a breast cancer survivor and one will be a blood relative. Study involves interviews, questionnaires, Use of Move Together app with Garmin activity tracker watch Move Together app/Garmin Activity Tracker: - The Move Together app allows users to set daily goals for increasing physical activity and decreasing sedentary time, track progress on goals, message their buddy, and access external educational infographics and other resource links. -Garmin activity tracker in this study is for participants to track their steps and sedentary time.
10
Total10

Baseline characteristics

CharacteristicPilot Study
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
2 Participants
Age, Categorical
Between 18 and 65 years
8 Participants
Age, Continuous45.9 years
Breast Cancer Status
Daughter of a survivor, no BRCA
1 Participants
Breast Cancer Status
Mother of a survivor, no BRCA
1 Participants
Breast Cancer Status
Niece of a survivor, no BRCA
1 Participants
Breast Cancer Status
Sister of a survivor, no BRCA
2 Participants
Breast Cancer Status
Survivor
5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
10 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
0 Participants
Region of Enrollment
United States
10 participants
Sex: Female, Male
Female
10 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 10
other
Total, other adverse events
0 / 10
serious
Total, serious adverse events
0 / 10

Outcome results

Primary

System Usability Scale (SUS) Score

The acceptability of the Move Together app will also be assessed with The System Usability Scale (SUS) score. The scale has 10 items. Scores range from 0-100; a SUS score above a 68 is considered above average (https://www.usability.gov/how-to-and-tools/methods/system-usability-scale.html.)

Time frame: Assessed at 4 Weeks

ArmMeasureValue (MEAN)Dispersion
Pilot StudySystem Usability Scale (SUS) Score72 units on a scaleStandard Deviation 14.3
Secondary

Completion Rate

number of participants who completed all aspects of the protocol

Time frame: 4 Weeks

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Pilot StudyCompletion Rate10 Participants
Secondary

Number of Participants Completed Study

Total number of participants who completed the study

Time frame: 4 weeks

ArmMeasureValue (NUMBER)
Pilot StudyNumber of Participants Completed Study9 number of participants
Secondary

Number of Participants Enrolled Per Month

number of participants consented to the study each month during enrollment period

Time frame: 4 month enrollment period

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Pilot StudyNumber of Participants Enrolled Per Month3 Participants
Secondary

Number of Participants Recruited

Number of initial respondents who consent and enroll.

Time frame: during 4 month recruitment period

ArmMeasureValue (NUMBER)
Pilot StudyNumber of Participants Recruited1 participants
Secondary

Number of Participants Retained at the End of 4 Weeks

Retention will be the number who remain in the study at the end of 4 weeks

Time frame: Baseline to 4 Weeks

ArmMeasureValue (NUMBER)
Pilot StudyNumber of Participants Retained at the End of 4 Weeks10 number of participants
Secondary

Number of Participants Screened Per Month

the number of participants screened per month during recruitment period (not cumulative)

Time frame: 4 month recruitment period

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Pilot StudyNumber of Participants Screened Per Month5 Participants
Secondary

Number of Study Days

number of study days in which the participants uses the Move Together app and will describe engagement with the app in a 28 day period (i.e., study days)

Time frame: baseline to 4 weeks (28 days)

ArmMeasureValue (MEAN)Dispersion
Pilot StudyNumber of Study Days17.1 daysStandard Deviation 8.6

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026